flecainide has been researched along with propafenone in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (11.56) | 18.7374 |
| 1990's | 72 (41.62) | 18.2507 |
| 2000's | 38 (21.97) | 29.6817 |
| 2010's | 36 (20.81) | 24.3611 |
| 2020's | 7 (4.05) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cappiello, E; Dalla Vecchia, L; Lombardi, F; Sandrone, G; Torzillo, D | 1 |
| Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M | 1 |
| Mason, R; Winslow, E | 1 |
| Brodherr-Heberlein, S; Engelhardt, W; Kienast, W; Kramer, HH; Lang, D; Lindinger, A; Schneider, P; Singer, H; Ulmer, H; von Bernuth, G | 1 |
| Baĭer, T; Brakhmann, I; Khilbel, T; Kiubler, V; Shmitt, K; Valdeker, B | 1 |
| Bertoldi, A; Dallago, M; Del Greco, M; Furlanello, F; Guarnerio, M; Inama, G; Vergara, G | 1 |
| Camm, AJ; Katritsis, D; Nunain, SO | 1 |
| Kingma, JH; Suttorp, MJ | 1 |
| Rabkin, SW | 1 |
| Auricchio, A | 1 |
| Cappiello, E; Castelli, A; Dalla Vecchia, L; Finocchiaro, ML; Lombardi, F; Pastine, J; Rech, R | 1 |
| Cavalli, A; Gaita, F; Giani, P; Landolina, M; Latini, R; Vincenti, A | 1 |
| Köppel, C; Peixoto-Menezes, KM; Tenczer, J | 1 |
| Camm, AJ; Garratt, CJ; Gill, J; Linker, NJ; O'Nunain, S; Ward, DE | 1 |
| Campbell, JK; Winslow, E | 1 |
| Barron, E; Campbell, JK; Marshall, RJ; Muir, AW; Winslow, E | 1 |
| Ewing, DJ; Latini, R; Neilson, JM; Schwartz, PJ; Zuanetti, G | 1 |
| Vaughan Williams, EM | 1 |
| Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Larbre, JP; Loufoua-Moundanga, J; Timour, Q | 1 |
| Braito, G; Furlanello, F; Guarnerio, M; Inama, G; Vergara, G | 1 |
| Inoue, H; Nozaki, A; Sugimoto, T; Yamashita, T | 1 |
| Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Kioueh, I; Loufoua-Moundanga, J; Timour, Q | 1 |
| Bonnet, D; Cohen, L; Kachaner, J; Le Bidois, J; Piéchaud, JF; Sidi, D; Villain, E | 1 |
| Marcus, FI | 1 |
| Desai, DM; Gal, J; Meyer-Lehnert, S | 1 |
| Sagie, A; Strasberg, B | 1 |
| Calvi, V; di Bona, G; Manzoli, U; Montenero, AS; Natale, A; Santarelli, P | 1 |
| Jessurun, ER; Kingma, JH; Lie, KI; Lie-A-Huen, L; Suttorp, MJ; van Hemel, NM | 1 |
| Kastrati, A; Kondili, A; Popa, Y | 1 |
| Gagnol, JP; Puech, P | 1 |
| Campbell, RW | 1 |
| Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F | 1 |
| Heinemeyer, G; Köppel, C; Oberdisse, U | 1 |
| Adam, WE; Haerer, W; Henze, E; Roth, J; Stauch, M | 1 |
| Kates, RE; Liem, LB | 1 |
| Abi Samra, F | 1 |
| Hoffman, BF; Spinelli, W | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Baudouy, M; Camous, JP; Gibelin, P; Ichai, C; Meyer, P; Morand, P; Varenne, A | 1 |
| Huang, SK; Marcus, FI | 1 |
| Touboul, P | 1 |
| Bonazzi, O; Facchini, M; Priori, SG; Schwartz, PJ; Varisco, T | 1 |
| Lanza, GA; Lucente, M; Mondello Malvestiti, FM; Rebuzzi, AG; Tamburi, S | 1 |
| Bald, R; Gembruch, U; Hansmann, M | 1 |
| Leclercq, JF | 1 |
| Podrid, PJ | 2 |
| Atarashi, H; Hayakawa, H | 1 |
| Sanna, GP | 1 |
| Somberg, JC | 1 |
| Fabry, E; Klempt, HW; Nayebagha, A | 1 |
| Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
| Grey, E; Silverman, DI | 1 |
| Malfatto, G; Schwartz, PJ; Zaza, A | 2 |
| Bonini, W; Botto, GL; Broffoni, T; Cappelletti, G; Falcone, C; Ferrari, G; Lombardi, R; Paulesu, A; Pedraglio, E | 1 |
| Prystowsky, EN | 1 |
| Malfatto, G; Pessano, P; Schwartz, PJ; Zaza, A | 1 |
| Auricchio, A; Auricchio, U; Chiariello, L | 1 |
| Binetti, N; Boriani, G; Botto, GL; Capucci, A; Cavazza, M; Della Casa, S; Falcone, C; Lenzi, T; Rubino, I; Trisolino, G | 1 |
| Arnese, M; Giunta, A; Maione, S; Matarazzi, C; Oppo, I; Palma, M; Santinelli, V | 1 |
| Gutiérrez-Larraya, F; Jabón, A | 1 |
| Castle, NA; Slawsky, MT | 1 |
| Cowan, JC | 1 |
| Lüderitz, B; Manz, M | 1 |
| Gomes, JA; Mannino, MM; Mehta, D | 1 |
| Higuchi, M; Itomine, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
| Aupetit, JF; Faucon, G; Kioueh, I; Larbre, JP; Lopez, M; Loufoua-Moundanga, J; Timour, Q | 1 |
| Akaike, N; Inomata, N; Ishihara, T; Ohno, T | 1 |
| Casadei, G; Chimienti, M; Cullen, MT | 2 |
| Aliot, E; Denjoy, I | 1 |
| Aouate, P; Benassar, A; Fontaine, G; Frank, R; Jacquemin, M; Laborde, JP; Tageddine, R; Tonet, J; Turlure, A | 1 |
| Beukema, WP; Defauw, JJ; Hoogteijling-van Dusseldorp, E; Kelder, JC; Kingma, JH; van Hemel, NM; Vermeulen, FE | 1 |
| Davini, A; Lattanzi, F; Paci, A; Paperini, L; Reisenhofer, B; Squarcini, G; Topi, A; Topi, PL | 1 |
| Briglia, N; Ducceschi, V; Esposito, R; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B; Scialdone, A | 1 |
| Broccolino, M; Mannucci, PM; Merlini, PA; Oltrona, L; Pezzano, A; Spinola, A | 1 |
| Burattini, M; Carunchio, A; Ceci, V; Coletta, C; Fera, MS; Galati, A; Mazza, A | 1 |
| Kuhn, RJ; Luedtke, SA; McCaffrey, FM | 1 |
| Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A | 1 |
| Bellandi, F; Cantini, F; Dabizzi, RP; Mugnaioni, G; Palchetti, R | 1 |
| Epstein, LM; Huang, DT; Josephson, ME; Monahan, KM; Papageorgiou, P; Zimetbaum, P | 1 |
| Biffi, M; Boriani, G; Botto, G; Branzi, A; Broffoni, T; Capucci, A; Magnani, B; Ongari, M; Rubino, I; Sanguinetti, M; Trisolino, G | 1 |
| Briglia, N; Ducceschi, V; Iacono, A; Mayer, MS; Santangelo, L; Sarubbi, B | 1 |
| Ciolli, A; De Sisti, A; Lo Sardo, G; Montenero, AS; Palamara, A; Sanna, T | 1 |
| Aschieri, D; Capucci, A; Piepoli, MF; Villani, GQ | 1 |
| Jung, W; Lewalter, T; Lüderitz, B; Schumacher, B; Vahlhaus, C; Wolpert, C | 1 |
| Nabar, A; Rodriguez, LM; Smeets, JL; Timmermans, C; Wellens, HJ | 1 |
| Biffi, M; Boriani, G; Branzi, A; Bronzetti, G; Capucci, A; Magnani, B | 1 |
| Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
| Camacho, C; Fernández-Gómez, JM; García-Garmendia, JL; Martínez-Marcos, FJ; Ortega-Carpio, A; Santos, JM | 1 |
| Beatty, G; Ceriotti, C; Coltorti, F; Galimberti, P; Gasparini, M; Mantica, M | 1 |
| Blitzer, M; Reiffel, JA | 1 |
| Caccavale, F; Catanzaro, M; Coppo, A; Corsini, F; Corsini, G; Di Maggio, O; Fattore, L; Iodice, E; Martone, A; Romano, A; Romano, S; Toscano, G | 1 |
| Knobloch, K; Wirth, KJ | 1 |
| Nabar, A; Rodriguez, LM; Timmermans, C; van Mechelen, R; Wellens, HJ | 1 |
| Alboni, P; Bongiorni, MG; Botto, GL; Brignole, M; Bruna, C; Gasparini, M; Menozzi, C; Ometto, R; Verlato, R; Vincenti, A | 1 |
| Hancox, JC; Paul, AA; Witchel, HJ | 1 |
| Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
| Bonso, A; Glatter, KA; Hongo, RH; Raviele, A; Rossillo, A; Scheinman, MM; Themistoclakis, S; Yang, Y | 1 |
| Dorian, P; Humphries, KH; Kerr, CR; Steinbuch, M | 1 |
| Beldner, S; Lin, D; Marchlinski, FE | 1 |
| Bertaglia, E; Bonso, A; Corò, L; Mantovan, R; Pascotto, P; Proclemer, A; Raviele, A; Themistoclakis, S; Verlato, R; Zoppo, F | 1 |
| Freestone, B; Lip, GY | 2 |
| Alboni, P; Baldi, N; Baroffio, R; Botto, GL; Calzolari, M; Gaggioli, G; Gianfranchi, L; Luzi, M; Marchi, P; Russo, V; Solano, A | 1 |
| Konety, SH; Olshansky, B | 1 |
| Almendral, J; Castillo, I; Martín, ML; Martínez-Sellés, M; Montenegro, P; Sanjurjo, M | 1 |
| Alboni, P; Baldi, N; Botto, GL | 1 |
| Wyse, DG | 1 |
| Scharf, C | 1 |
| Lip, GY | 1 |
| Hoffmann, E; Janko, S | 1 |
| Akhtar, M; Narayan, G; Sra, J | 1 |
| Camm, AJ; Savelieva, I | 1 |
| Fodstad, H; Kontula, K; Laitinen-Forsblom, P; Lehtonen, A; Swan, H; Toivonen, L | 1 |
| Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
| Boriani, G; Chiarandà, G; Colletti, A; Di Giovanni, N; Grammatico, A; Gulizia, M; Lisi, F; Mangiameli, S; Orazi, S; Pensabene, O; Piccione, G; Vasquez, L | 1 |
| Breithardt, G; Camm, J; Crijns, H; Dorian, P; Kowey, PR; Le Heuzey, JY; Pedrazzini, L; Prystowsky, EN; Salette, G; Schwartz, PJ; Torp-Pedersen, C; Weintraub, W | 1 |
| Alboni, P; Boriani, G; Botto, GL; Capucci, A; Iori, M; Mancini, M; Mariconti, B; Pacchioni, F; Pasanisi, G; Russo, G | 1 |
| Stiefelhagen, P | 1 |
| Anusionwu, O; Wali, A | 1 |
| Garic, B; Madeja, M; Mesic, I; Steffen, W; Zhorov, BS | 1 |
| Abbate, R; Conti, A; Del Taglia, B; Gensini, GF; Grifoni, S; Mariannini, Y; Michelucci, A; Padeletti, L; Pepe, G; Vanni, S | 1 |
| Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M | 1 |
| Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H | 1 |
| Kong, DF; Piccini, JP | 1 |
| Galimberti, ES; Knollmann, BC | 1 |
| Daniell, HW | 1 |
| Balla, I; Kondili, A; Petrela, E | 1 |
| Avetisyan, R; Bash, LD; Buono, JL; Davies, GM; Fahrbach, K; Martin, A; Mwamburi, M; Phatak, H | 1 |
| Alegret, JM; Freire, F; Romero-Menor, C; Viñolas, X | 1 |
| Cosedis Nielsen, J; Englund, A; Hansen, PS; Hartikainen, J; Hindricks, G; Johannessen, A; Kongstad, O; Mortensen, LS; Pehrson, S; Raatikainen, P; Walfridsson, H | 1 |
| Aragon, M; Caro, M; Conde, D; Costabel, JP; Ferro, A; Giniger, A; Klein, A; Trivi, M | 1 |
| Conde, D | 1 |
| Aragon, M; Conde, D; Costabel, JP; Lambardi, F; Trivi, M | 1 |
| Eggertson, L | 1 |
| Carbonara, R; Conte Camerino, D; Costanza, T; Desaphy, JF | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L | 1 |
| Aronsson, M; Englund, A; Hansen, PS; Hartikainen, J; Hindricks, G; Janzon, M; Johannessen, A; Kongstad, O; Levin, LA; Mortensen, LS; Nielsen, JC; Pehrson, S; Raatikainen, P; Walfridsson, H; Walfridsson, U | 1 |
| Deshmukh, A; Paydak, H; Pothineni, NV; Vallurupalli, S | 1 |
| Knollmann, BC; Savio-Galimberti, E | 1 |
| Johnson-Davis, KL; Slawson, MH | 1 |
| Fauchier, L; Freedman, SB; Gianni, C; Lane, DA; Lip, GY; Natale, A; Nattel, S; Potpara, T; Rienstra, M; Tse, HF; Van Gelder, I | 1 |
| Bonora, A; Dilda, A; Franchi, E; Maccagnani, A; Olivieri, O; Pistorelli, C; Taioli, G; Turcato, G; Zerman, G | 1 |
| Arkles, J; Callans, DJ; Dixit, S; Epstein, AE; Frankel, DS; Hyman, MC; Lin, D; Marchlinski, FE; Muser, D; Mustin, D; Nazarian, S; Santangeli, P; Schaller, RD; Supple, G | 1 |
| Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C | 1 |
| Frankel, DS | 1 |
| Capucci, A; Ciliberti, G; Guerra, F | 1 |
| Apicella, C; Fabritz, L; Fobian, D; Gupta, S; Holmes, AP; Kabir, SN; Kirchhof, P; Kuhlmann, SM; O'Reilly, M; O'Shea, C; Pavlovic, D; Reyat, JS; Saxena, P; Smith, GL; Syeda, F; Workman, AJ | 1 |
| Antoniou, CK; Doundoulakis, I; Gatzoulis, KA; Pagkalidou, E; Stefanadis, C; Tsiachris, D; Tsioufis, K; Tsioufis, P; Zafeiropoulos, SM | 1 |
| Duru, F; Eriksson, U; Kovacs, B; Krasniqi, N; Yakupoglu, HY | 1 |
| Arkles, JS; Callans, DJ; Deo, R; Dixit, S; Epstein, AE; Frankel, DS; Guandalini, GS; Hyman, MC; Jarrah, AA; Lin, D; Marchlinski, FE; Markman, TM; Mustin, E; Nazarian, S; Riley, M; Santangeli, P; Schaller, RD; Supple, GE; Tian, Y | 1 |
| Balsam, P; Basza, M; Bojanowicz, W; Daniłowicz-Szymanowicz, L; Grabowski, M; Jaguszewski, M; Kalarus, Z; Kempa, M; Kowalski, O; Kołtowski, Ł; Lubiński, A; Maciejewski, C; Mitkowski, P; Sterliński, M; Szumowski, Ł | 1 |
| Bukumirić, Z; Jurčević, R; Kojić, D; Marić, M; Radunović, A; Rajsic, S; Sušić, M; Tomović, M; Žugić, V | 1 |
| Alexander, ME; Bezzerides, VJ; DeWitt, ES; Dionne, A; Eberly, LM; Mah, DY; O'Leary, ET; Przybylski, R; Triedman, JK; Walsh, EP | 1 |
35 review(s) available for flecainide and propafenone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Encainide; Flecainide; Humans; Propafenone | 1991 |
[Incessant idiopathic ventricular tachycardia in infants].
Topics: Amiodarone; Cardiomyopathies; Child, Preschool; Electrocardiography; Female; Flecainide; Follow-Up Studies; Heart Neoplasms; Heart Ventricles; Humans; Infant; Intracranial Embolism and Thrombosis; Male; Prognosis; Propafenone; Tachycardia | 1990 |
[Class Ic antiarrhythmic drugs--flecainide and propafenone].
Topics: Arrhythmias, Cardiac; Flecainide; Humans; Propafenone | 1990 |
Class IC drugs: propafenone and flecainide.
Topics: Arrhythmias, Cardiac; Flecainide; Humans; Propafenone | 1990 |
Is drug treatment of tachyarrhythmias a science or a lottery?
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Flecainide; Humans; Propafenone; Tachycardia | 1990 |
Update: cardiac antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Propafenone; Propanolamines | 1989 |
The clinical use of class IC antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Propafenone | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia.
Topics: Ambulatory Care; Anti-Arrhythmia Agents; Cardiomyopathies; Flecainide; Hospitalization; Humans; Propafenone; Risk; Tachycardia, Supraventricular; Time Factors | 1994 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Propafenone; Tachycardia, Supraventricular | 1995 |
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Ventricular Dysfunction | 1995 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Child, Preschool; Digoxin; Flecainide; Humans; Infant; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1997 |
The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Flecainide; Humans; Propafenone | 1999 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Timolol; Verapamil | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2004 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
Atrial fibrillation (recent onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2005 |
[Drug treatment of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Drug Therapy, Combination; Echocardiography; Electric Countershock; Electrocardiography; Flecainide; Heart Diseases; Heart Rate; Humans; Monitoring, Physiologic; Multicenter Studies as Topic; Propafenone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Time Factors | 2006 |
Some patients with paroxysmal atrial fibrillation should carry flecainide or propafenone to self treat.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Propafenone; Self Care | 2007 |
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome | 2011 |
Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation.
Topics: Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Bayes Theorem; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Pyrrolidines; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Countershock; Flecainide; Heart Failure; Heart Rate; Humans; Hypertension; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Propafenone; Quality of Life; Risk Factors; Sodium Channel Blockers; Stroke; Thromboembolism; Warfarin | 2016 |
Reappraising the role of class Ic antiarrhythmics in atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Propafenone; Randomized Controlled Trials as Topic | 2022 |
Flecainide in clinical practice.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Female; Flecainide; Humans; Pregnancy; Propafenone; Tachycardia, Ventricular | 2023 |
34 trial(s) available for flecainide and propafenone
| Article | Year |
|---|---|
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Life Tables; Male; Middle Aged; Myocardial Ischemia; Propafenone; Survival Analysis; Survival Rate; Tachycardia, Ventricular | 1992 |
Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome.
Topics: Atrial Fibrillation; Atrial Function; Cardiac Catheterization; Cardiac Pacing, Artificial; Flecainide; Heart Conduction System; Humans; Propafenone; Wolff-Parkinson-White Syndrome | 1992 |
Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
Topics: Atrial Fibrillation; Atrial Flutter; Drug Evaluation; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Single-Blind Method; Time Factors; Verapamil | 1992 |
Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection.
Topics: Adult; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Artificial; Exercise; Exercise Test; Female; Flecainide; Heart Rate; Humans; Male; Propafenone; Prospective Studies; Wolff-Parkinson-White Syndrome | 1992 |
Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Flecainide; Heart Diseases; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Substance Withdrawal Syndrome; Time Factors | 1992 |
A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Flecainide; Humans; Male; Propafenone; Tachycardia, Atrioventricular Nodal Reentry; Wolff-Parkinson-White Syndrome | 1991 |
The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Topics: Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Single-Blind Method; Time Factors | 1990 |
Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm.
Topics: Adult; Aged; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Verapamil | 1990 |
Long term inotropic effects of flecainide and propafenone.
Topics: Administration, Oral; Adult; Cardiac Complexes, Premature; Clinical Trials as Topic; Exercise Test; Female; Flecainide; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Propafenone; Prospective Studies; Radionuclide Imaging; Random Allocation; Rest; Stroke Volume; Time Factors | 1988 |
[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography; Flecainide; Half-Life; Heart Rate; Heart Ventricles; Humans; Mexiletine; Middle Aged; Myocardial Infarction; Piperidines; Propafenone; Propiophenones | 1982 |
Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
Topics: Atrial Fibrillation; Digoxin; Electrocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Propafenone; Ventricular Function | 1994 |
Partial reversal by exercise of protective effect in atrial fibrillation inducibility in patients with an accessory atrioventricular connection: comparison between flecainide and propafenone.
Topics: Adult; Arrhythmias, Cardiac; Electric Stimulation; Exercise Test; Female; Flecainide; Humans; Male; Middle Aged; Physical Exertion; Propafenone; Prospective Studies; Wolff-Parkinson-White Syndrome | 1994 |
Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function.
Topics: Adolescent; Adult; Blood Pressure; Echocardiography; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Propafenone; Reference Values; Single-Blind Method; Systole; Tachycardia, Paroxysmal; Ventricular Function, Left | 1993 |
Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Follow-Up Studies; Humans; Italy; Life Tables; Male; Middle Aged; Propafenone | 1996 |
Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
Topics: Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Flecainide; Follow-Up Studies; France; Humans; Life Tables; Male; Middle Aged; Propafenone | 1996 |
Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Treatment Outcome | 1995 |
Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Sotalol; Survival Analysis; Tachycardia, Ventricular; Treatment Failure | 1996 |
[Propafenone and flecainide in the therapy of ventricular arrhythmias].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Drug Evaluation; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Ventricular Dysfunction | 1995 |
[Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol | 1997 |
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Time Factors | 1998 |
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler; Female; Flecainide; Heart Conduction System; Humans; Injections, Intravenous; Male; Probability; Propafenone; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2000 |
Noncontact system-guided simplified right atrial linear lesions using radiofrequency transcatheter ablation for treatment of refractory atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Flecainide; Follow-Up Studies; Heart Atria; Humans; Male; Middle Aged; Propafenone; Treatment Outcome; Tricuspid Valve; Vena Cava, Inferior | 2000 |
[Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Time Factors | 2001 |
An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Catheter Ablation; Echocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Pacemaker, Artificial; Propafenone; Prospective Studies; Quality of Life; Sotalol; Time Factors | 2002 |
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Italy; Male; Middle Aged; Propafenone; Prospective Studies; San Francisco; Sulfonamides; Treatment Outcome | 2004 |
Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
Topics: Administration, Oral; Ambulatory Care; Anti-Arrhythmia Agents; Atrial Fibrillation; Feasibility Studies; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Self Administration; Stroke Volume | 2004 |
[Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feasibility Studies; Flecainide; Humans; Italy; Middle Aged; Propafenone; Treatment Outcome | 2005 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Male; Probability; Propafenone; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Sotalol; Statistics, Nonparametric; Survival Rate; Treatment Outcome | 2008 |
Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Glycosides; Cardiotonic Agents; Clinical Competence; Female; Flecainide; Health Care Surveys; Health Knowledge, Attitudes, Practice; Heart Rate; Humans; Internationality; Male; Middle Aged; Practice Guidelines as Topic; Propafenone; Prospective Studies; Registries; Sotalol; Surveys and Questionnaires | 2010 |
Management of patients with acute atrial fibrillation in the ED.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Emergency Service, Hospital; Female; Flecainide; Humans; Injections, Intravenous; Length of Stay; Male; Propafenone; Time Factors; Treatment Outcome | 2010 |
Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Treatment Outcome | 2011 |
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Cost of Illness; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Middle Aged; Propafenone; Quality of Life; Statistics, Nonparametric; Treatment Outcome | 2012 |
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cost of Illness; Female; Flecainide; Health Status; Humans; Male; Middle Aged; Propafenone; Quality of Life; Treatment Outcome | 2015 |
105 other study(ies) available for flecainide and propafenone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Autonomic effects of antiarrhythmic drugs and their importance.
Topics: Adult; Autonomic Nervous System; Cardiac Complexes, Premature; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Male; Mexiletine; Middle Aged; Propafenone; Tachycardia, Ventricular; Ventricular Fibrillation | 1992 |
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone | 1992 |
Comparative hemodynamic effects of Org 7797, flecainide, and propafenone in anesthetized pigs with developing myocardial infarcts.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Estrenes; Female; Flecainide; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Organ Size; Propafenone; Swine; Time Factors; Ventricular Function, Left | 1992 |
Atrial automatic tachycardia in infancy and childhood.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Infant; Male; Prognosis; Propafenone; Tachycardia, Ectopic Atrial | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Flecainide; Humans; Mexiletine; Middle Aged; Propafenone; Quinidine | 1992 |
Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
Topics: Adult; Cardiac Pacing, Artificial; Female; Flecainide; Follow-Up Studies; Humans; Male; Propafenone; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Time Factors | 1992 |
Effect of antiarrhythmic drugs on choline uptake in cardiac cells in culture.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chick Embryo; Choline; Dose-Response Relationship, Drug; Encainide; Flecainide; Heart; Lidocaine; Myocardium; Propafenone; Tocainide | 1992 |
Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography, Ambulatory; Female; Flecainide; Heart Diseases; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Propafenone; Signal Processing, Computer-Assisted; Tachycardia | 1992 |
Formation of formaldehyde adducts from various drugs by use of methanol in a toxicological screening procedure with gas chromatography-mass spectrometry.
Topics: Adrenergic beta-Antagonists; Flecainide; Formaldehyde; Gas Chromatography-Mass Spectrometry; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Poisoning; Prilocaine; Propafenone | 1991 |
Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Estrenes; Flecainide; Guinea Pigs; Heart; In Vitro Techniques; Male; Propafenone; Refractory Period, Electrophysiological; Sodium Channels | 1991 |
Effects of Org 7797 on early, late and inducible arrhythmias following coronary artery occlusion in rats and dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Estrenes; Female; Flecainide; Hemodynamics; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Propafenone; Rats; Rats, Inbred Strains; Tachycardia; Ventricular Fibrillation | 1991 |
Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Propafenone; Reproducibility of Results; Survival Rate | 1991 |
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Disease Models, Animal; Flecainide; Imidazoles; Injections, Intravenous; Propafenone; Swine | 1991 |
[Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
Topics: Adolescent; Adult; Cardiac Pacing, Artificial; Drug Evaluation; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Prognosis; Propafenone; Retrospective Studies; Tachycardia, Paroxysmal; Tachycardia, Supraventricular | 1991 |
Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Piperidines; Propafenone; Pyridines; Refractory Period, Electrophysiological | 1991 |
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Disease; Coronary Vessels; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Propafenone; Swine; Ventricular Fibrillation | 1991 |
The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Encainide; Flecainide; Hemodynamics; Humans; Propafenone | 1990 |
Reversed-phase LC resolutions of chiral antiarrhythmic agents via derivatization with homochiral isothiocyanates.
Topics: Anti-Arrhythmia Agents; Chromatography, Liquid; Flecainide; Humans; Indicators and Reagents; Lidocaine; Male; Mexiletine; Propafenone; Thiocyanates; Tocainide | 1990 |
Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
Topics: Administration, Oral; Cardiac Pacing, Artificial; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Middle Aged; Propafenone; Tachycardia, Supraventricular; Time Factors; Wolff-Parkinson-White Syndrome | 1990 |
Arrhythmogenic effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil | 1990 |
Clinical course and outcome in class IC antiarrhythmic overdose.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bicarbonates; Bradycardia; Drug Overdose; Flecainide; Hemoperfusion; Humans; Hypertonic Solutions; Nausea; Prajmaline; Propafenone; Resuscitation; Retrospective Studies; Sodium; Sodium Bicarbonate; Tachycardia; Vomiting | 1990 |
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol | 1989 |
[Treatment of poisoning caused by new anti-arrhythmia agents (cibenzoline, flecainide and propafenone)].
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Flecainide; Humans; Imidazoles; Lactates; Lactic Acid; Male; Middle Aged; Propafenone | 1987 |
[New class I anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Bepridil; Flecainide; Humans; Imidazoles; Kinetics; Propafenone; Pyrrolidines | 1986 |
Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; Drug Administration Schedule; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Male; Mexiletine; Middle Aged; Propafenone; Propylamines; Pyridines | 1987 |
[Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Monitoring, Physiologic; Propafenone | 1988 |
Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Medigoxin; Pregnancy; Propafenone; Tachycardia; Verapamil | 1988 |
[New antiarrhythmia agents: propafenone and flecainide].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Flecainide; Heart Conduction System; Humans; Piperidines; Propafenone; Propiophenones | 1985 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
[Anti-arrhythmia agents (I): Quinidine, procainamide, disopyramide, encainide, propafenone and flecainide].
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Efficacy of type 1C antiarrhythmic agents for treatment of resistant atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Encainide; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Procainamide; Propafenone; Quinidine; Recurrence; Retrospective Studies | 1993 |
Modulation of the electrical restitution of canine Purkinje fibers by local anesthetic drugs: a study with flecainide and propafenone.
Topics: Action Potentials; Anesthetics, Local; Animals; Dogs; Electrophysiology; Female; Flecainide; In Vitro Techniques; Male; Propafenone; Purkinje Fibers | 1994 |
Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cats; Electric Stimulation; Electrocardiography; Female; Flecainide; Heart Rate; Male; Propafenone; Propranolol | 1993 |
Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide.
Topics: Administration, Oral; Aged; Atrial Fibrillation; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Time Factors | 1994 |
Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Female; Flecainide; Male; Membrane Potentials; Models, Biological; Propafenone; Purkinje Fibers; Time Factors | 1994 |
K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
Topics: Animals; Anti-Arrhythmia Agents; Cells, Cultured; Electrophysiology; Flecainide; Heart; Heart Ventricles; Kinetics; Potassium Channels; Propafenone; Quinidine; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 1994 |
Antiarrhythmic drugs in the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Flecainide; Heart; Humans; Propafenone; Quinidine | 1993 |
Current treatment options for paroxysmal supraventricular tachycardia.
Topics: Acute Disease; Catheter Ablation; Chronic Disease; Flecainide; Humans; Propafenone; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1994 |
Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
Topics: Anesthesia, Intravenous; Animals; Anti-Arrhythmia Agents; Depression, Chemical; Dogs; Female; Flecainide; Heart; Hemodynamics; Lidocaine; Male; Myocardial Contraction; Propafenone | 1993 |
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Myocardial Ischemia; Propafenone; Swine | 1993 |
Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Conductivity; Flecainide; Guinea Pigs; Lidocaine; Male; Myocardium; Potassium; Potassium Channels; Propafenone | 1993 |
[Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Sotalol; Ventricular Function | 1996 |
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Antithrombin III; Atrial Fibrillation; Biomarkers; Disease Susceptibility; Female; Fibrinopeptide A; Flecainide; Hemostasis; Humans; Male; Middle Aged; Peptide Hydrolases; Propafenone; Thrombin; Thromboembolism | 1997 |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors | 1997 |
[Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Data Interpretation, Statistical; Echocardiography, Doppler, Pulsed; Female; Flecainide; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Propafenone; Quinidine; Recurrence; Time Factors | 1997 |
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Quinidine | 1998 |
Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Sotalol; Ventricular Function | 1998 |
[Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Doppler; Electric Countershock; Female; Flecainide; Heart Atria; Humans; Male; Middle Aged; Myocardial Stunning; Propafenone; Statistics, Nonparametric; Time Factors | 1998 |
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Combined Modality Therapy; Electrocardiography; Electrocardiography, Ambulatory; Flecainide; Follow-Up Studies; Humans; Propafenone; Prospective Studies; Recurrence; Registries; Surveys and Questionnaires; Treatment Outcome | 1999 |
Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Defibrillators, Implantable; Electrocardiography; Female; Flecainide; Follow-Up Studies; Heart Atria; Humans; Male; Middle Aged; Propafenone; Recurrence; Reoperation; Treatment Outcome | 1999 |
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
Topics: Adrenergic beta-Agonists; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Humans; Isoproterenol; Male; Middle Aged; Propafenone; Prospective Studies; Signal Processing, Computer-Assisted; Stimulation, Chemical | 1999 |
The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Sodium Channels; Sulfonamides | 2000 |
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrial Function, Right; Flecainide; Male; Phenethylamines; Propafenone; Sulfonamides; Swine | 2001 |
Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Electrocardiography; Female; Flecainide; Heart Atria; Humans; Male; Middle Aged; Propafenone; Retrospective Studies | 2001 |
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Topics: Cation Transport Proteins; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Flecainide; Humans; Lidocaine; Neural Inhibition; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone; Quinidine; Trans-Activators; Transcriptional Regulator ERG | 2002 |
Atrial fibrillation: rate control often better than rhythm control.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Arrhythmia, Sinus; Atrial Fibrillation; Canada; Disopyramide; Electric Countershock; Flecainide; Heart Rate; Humans; Netherlands; Platelet Aggregation Inhibitors; Propafenone; Quinidine; Sotalol; United States | 2004 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Contraindications; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Quinidine; Registries; Sotalol | 2004 |
Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Flecainide; Follow-Up Studies; Humans; Propafenone; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2004 |
Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Cohort Studies; Disease-Free Survival; Echocardiography; Female; Flecainide; Follow-Up Studies; Forecasting; Humans; Longitudinal Studies; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Risk Factors; Time Factors | 2004 |
The "pill-in-the-pocket" approach to atrial fibrillation.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Control Groups; Flecainide; Humans; Propafenone; Self Administration | 2005 |
[Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cytochrome P-450 CYP2D6; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Pharmacogenetics; Polymorphism, Genetic; Propafenone; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Heart Rate; Humans; Middle Aged; Propafenone; Prospective Studies; Self Administration; Surveys and Questionnaires; Treatment Outcome | 2005 |
Combined use of 1C and III agents for highly symptomatic, refractory atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Drug Combinations; Female; Flecainide; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Secondary Prevention; Sotalol; Sulfonamides; Treatment Failure; Treatment Outcome | 2006 |
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; DNA Mutational Analysis; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Finland; Flecainide; Founder Effect; Genetic Predisposition to Disease; Genetic Testing; Heart Conduction System; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Middle Aged; Mutation; Propafenone; Risk Factors; Sotalol; Torsades de Pointes; Treatment Outcome | 2007 |
Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Flecainide; Hospitalization; Humans; Infusions, Intravenous; Middle Aged; Propafenone; Self Administration; Tablets; Young Adult | 2010 |
[Instead of long-term antiarrhythmia drug treatment--stand-by therapy for atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Drug Administration Schedule; Electrocardiography; Flecainide; Humans; Long-Term Care; Propafenone | 2010 |
'Pill-in-the-pocket' treatment for recent-onset atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Humans; Infusions, Intravenous; Male; Propafenone; Self Administration | 2010 |
Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1.
Topics: Animals; Anti-Arrhythmia Agents; Binding Sites; Flecainide; Gene Expression Regulation; Humans; Hydrogen Bonding; Monte Carlo Method; Oocytes; Propafenone; Protein Binding; Rats; Shab Potassium Channels; Structure-Activity Relationship; Xenopus laevis | 2010 |
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defibrillators, Implantable; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Flecainide; Humans; Ion Channel Gating; Lidocaine; Male; Mice; Mice, Knockout; Mutation, Missense; Myocytes, Cardiac; Procainamide; Propafenone; Ryanodine Receptor Calcium Release Channel; Sodium Channel Blockers; Tachycardia, Ventricular; Time Factors; Young Adult | 2011 |
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome | 2011 |
Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Signaling; Calsequestrin; Cell Membrane Permeability; Cells, Cultured; Disease; Dose-Response Relationship, Drug; Flecainide; Humans; Inhibitory Concentration 50; Mice; Mice, Knockout; Microscopy, Confocal; Molecular Imaging; Myocytes, Cardiac; Propafenone; Saponins; Stereoisomerism; Tachycardia, Ventricular | 2011 |
Syncope following 'pill-in-the-pocket' treatment of atrial fibrillation with propafenone plus quinidine.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Propafenone | 2011 |
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Mass Index; Comorbidity; Diabetes Mellitus; Female; Flecainide; Heart Rate; Heart Valve Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prognosis; Propafenone; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Remission Induction; Sotalol; Time Factors; Treatment Outcome | 2013 |
Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.
Topics: Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Europe; Flecainide; Humans; Practice Guidelines as Topic; Propafenone; Pyrrolidines | 2013 |
Conversion of recent onset atrial fibrillation: which drug is faster?
Topics: Administration, Oral; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Injections, Intravenous; Propafenone; Pyrrolidines; Time Factors | 2013 |
Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.
Topics: Administration, Oral; Aged; Anisoles; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flecainide; Health Status; Humans; Injections, Intravenous; Male; Middle Aged; Perception; Propafenone; Prospective Studies; Pyrrolidines; Quality of Life; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2014 |
Three heart medications in short supply in Canada.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Flecainide; Humans; Phenethylamines; Propafenone; Sulfonamides | 2014 |
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Topics: Animals; Carbamazepine; Disease Models, Animal; Flecainide; HEK293 Cells; Humans; Mexiletine; Muscle, Skeletal; Myotonia Congenita; Orphenadrine; Piperidines; Propafenone; Rats; Rats, Wistar; Riluzole; Sodium Channel Blockers; Thiazoles | 2014 |
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol | 2015 |
Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone).
Topics: Arkansas; Cardiomyopathies; Echocardiography; Electrocardiography; Exercise Test; Female; Flecainide; Follow-Up Studies; Heart Conduction System; Heart Rate; Heart Ventricles; Humans; Incidence; Male; Middle Aged; Propafenone; Reproducibility of Results; Retrospective Studies; Survival Rate; Tachycardia, Ectopic Atrial; Ventricular Function; Voltage-Gated Sodium Channel Blockers | 2015 |
Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Calcium Signaling; Calsequestrin; Cell Membrane Permeability; Flecainide; Heart Ventricles; Humans; Inhibitory Concentration 50; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Propafenone; Rabbits; Ryanodine Receptor Calcium Release Channel; Tetracaine | 2015 |
Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Flecainide; Humans; Mexiletine; Propafenone; Tandem Mass Spectrometry | 2016 |
Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Pharmacological Phenomena; Propafenone; Propensity Score; Retrospective Studies; Treatment Outcome | 2017 |
Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Flecainide; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Pennsylvania; Propafenone; Retrospective Studies; Survival Rate; Ventricular Function, Left; Ventricular Premature Complexes | 2018 |
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol | 2018 |
Reply to the Editor- Flecainide and Propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Ventricular Premature Complexes | 2018 |
To the Editor- Flecainide and propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Flecainide; Humans; Propafenone; Ventricular Premature Complexes | 2018 |
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Female; Flecainide; Heart Atria; Male; Membrane Potentials; Mice; Propafenone; Sodium; Voltage-Gated Sodium Channel Blockers | 2021 |
Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Flecainide; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Tertiary Healthcare | 2023 |
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Flecainide; Humans; Hypotension; Male; Middle Aged; Propafenone; Retrospective Studies | 2022 |
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Retrospective Studies; Sotalol; Ventricular Premature Complexes | 2023 |
Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Flecainide; Heart Defects, Congenital; Humans; Propafenone; Retrospective Studies; Tachycardia; Tachycardia, Supraventricular | 2023 |